logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

NetVation DL Medicine Announces Research Collaboration With Pfizer,中国生物科技公司科辉先导与辉瑞合作,开展药物筛选

NetVation DL Medicine Announces Research Collaboration With Pfizer

Feb 6, 2018

Life Science

NAI500-China-news-Weekly-mining-oil-gas-life science-technology-Chinese investors-Chinese investment-ODI-Where Chinese Investors Meet Global Investment News and Opportunities

China News Weekly 48 – UK signs over 9 billion pounds in deals during PM’s China trip

Feb 6, 2018

Life Science, Technology

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Engages Consulting Group to Make Application To Become Licensed Dealer

Feb 6, 2018

Life Science, Technology

biotech out of Oxford is developing vaccine

A biotech out of Oxford is developing a vaccine to fight every type of flu

Feb 5, 2018

Life Science

VolitionRX Ltd NYSE:VNRX

VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark

Feb 5, 2018

Life Science

Lexaria Bioscience CSE:LXX Biotechnology, Cannabis, 生物科技,大麻

Lexaria Announces Exercises of Existing Warrants

Feb 2, 2018

Life Science

Life Science & Technology Weekly 130 – Grown inside 3D-printed molds: new ears for children

Feb 1, 2018

Life Science, Technology

Maple Leaf Green World Inc TSXV:MGW Agriculture, Biotechnology, Consumer Products and Services, Cannabis, 农业,生物科技,消费品,大麻

Maple Leaf Anticipates the Completion of Its Telkwa, B.C. Facility in Early Summer 2018

Jan 31, 2018

Life Science, Technology

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Announces $3,200,000 Private Placement

Jan 26, 2018

Life Science, Technology

Lexaria Bioscience CSE:LXX Biotechnology, Cannabis, 生物科技,大麻

Lexaria Enters Licensing Agreement with Canadian Cannabis Chocolate Manufacturer

Jan 25, 2018

Life Science, Technology

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel CEO Provides 2018 Shareholder Update

Jan 25, 2018

Life Science, Technology

NAI Life Science Weekly - www.nai500.com

Life Science & Technology Weekly 129 – Two monkeys were cloned in China to help with cancer research

Jan 25, 2018

Life Science, Technology

Maple Leaf Green World Inc TSXV:MGW Agriculture, Biotechnology, Consumer Products and Services, Cannabis, 农业,生物科技,消费品,大麻

Maple Leaf Provides an Update on its American Medical Cannabis Operations

Jan 24, 2018

Life Science, Technology

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Warrant and Option Exercise Raises $391,170

Jan 23, 2018

Life Science, Technology

NAI Life Science Weekly - www.nai500.com

Life Science & Technology Weekly 128 – First Chronic Hepatitis B Patient Dosed in China in a Phase I Trial of T101 (Transgene’s TG1050 Technology)

Jan 18, 2018

Life Science, Technology

Lexaria Bioscience CSE:LXX Biotechnology, Cannabis, 生物科技,大麻

Lexaria Announces Exercises of Existing Warrants

Jan 17, 2018

Life Science, Technology

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Lands Commitment for Key Investment Partnership

Jan 16, 2018

Life Science, Technology

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial

Jan 11, 2018

Life Science, Technology

  • ‹‹ Previous
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada